BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4393836)

  • 1. [Effects of pyridinocarbamate in chronic cerebral arteriosclerosis].
    de Oliveira JM
    Hospital (Rio J); 1970 Feb; 77(2):441-50. PubMed ID: 4393836
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of buflomedil on the behavior of platelet aggregation and its clinical evaluation in elderly patients with chronic cerebrovascular insufficiency].
    Cajozzo A; Abbadessa V; Musso M; Iannitto E
    Minerva Med; 1983 Jul; 74(28-29):1727-31. PubMed ID: 6346139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vincamine in the treatment of cerebral circulatory insufficiency in old age].
    Turrisi E; D'Alise R; Mea A; Vitagliano A
    Minerva Cardioangiol; 1975 Jan; 23(1):20-32. PubMed ID: 1143645
    [No Abstract]   [Full Text] [Related]  

  • 4. [Place of combined cinnarizine-heptanol acefyllinate in treatment of vertigo and ear buzzing of vascular origin].
    Calvet J; Coll J; Stefani JM
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Feb; 18(2):127-30. PubMed ID: 4392741
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic experience with the use of piritinol (Encephabol) in geriatrics].
    Romano F
    Minerva Med; 1970 Jun; 61(51):2875-7. PubMed ID: 5432045
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of circuletin-F on peripheral circulation disorders in essential hypertension and cerebral arteriosclerosis -- study by a double-blind method].
    Tahara T; Yoshisaka K
    Horumon To Rinsho; 1975 Mar; 23(3):265-72. PubMed ID: 1102155
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with the use of pangamic acid (vitamin B-15) in arteriosclerosis of the vessels of the brain with mental disorders].
    Rastopchin IP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(2):264-7. PubMed ID: 5439840
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of pyridinol carbamate treatment of coronary atherosclerosis].
    Aguirre LV; Eseverri JL; Fajardo D; Ciliberti E; Quijano E; Lucerelli R
    Prensa Med Argent; 1970 Jun; 57(16):778-83. PubMed ID: 5457375
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of moxisylyte hydrochloride].
    Cloarec M
    Clin Ter; 1970 Dec; 55(6):503-12. PubMed ID: 4252473
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results obtained with pyridinocarbamate in the treatment of atherosclerosis in different parta of the body].
    Bronstein J; Galeano JC; Soutric JL; Steinman J; Novaro Hueyo JA
    Prensa Med Argent; 1969 Oct; 56(32):1543-9. PubMed ID: 5405011
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled, double-blind study of dl-alpha-tocopheryl nicotinate (Juvela-Nicotinate) for treatment of symptoms in hypertension and cerebral arteriosclerosis.
    Iino K; Abe K; Kariya S; Kimura H; Kusaba T
    Jpn Heart J; 1977 May; 18(3):277-83. PubMed ID: 881743
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sleep disorders, their origin and treatment].
    Heimann H; Schmocker AM
    Rev Med Suisse Romande; 1974 Jul; 94(7):525-32. PubMed ID: 4842889
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with proxazole in the therapy of cerebrovascular diseases].
    Mainieri L
    Minerva Med; 1974 May; 65(40):2281-6. PubMed ID: 4422429
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of treatment with Melitracen (trausabun) in depressive states].
    Wojdyslawska I
    Psychiatr Pol; 1970; 4(4):449-53. PubMed ID: 5472582
    [No Abstract]   [Full Text] [Related]  

  • 15. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L
    Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug therapy of physical and mental manifestations of fatigue in geriatrics].
    Cocchi C; Provvedini D; Daccò L
    Clin Ter; 1980 Apr; 93(1):89-97. PubMed ID: 6108819
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some aspects of mental disorders in cerebral arteriosclerosis].
    Grecu G; Pascu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1978; 23(1):45-51. PubMed ID: 653158
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial of a new tranquilizing agent: trioxazine].
    Taverna P; Ferrari G
    Minerva Med; 1970 Jun; 61(46):2574-90. PubMed ID: 5425739
    [No Abstract]   [Full Text] [Related]  

  • 19. [Captagon--a new psychotonic agent].
    Bryś J; Tomaszewski K; Wasik A; Bukowczyk A
    Psychiatr Pol; 1969; 3(3):341-6. PubMed ID: 5805112
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental investigations on drug induced improvement of brain metabolism].
    Köhler W
    Wien Klin Wochenschr; 1972 May; 84(21):340-3. PubMed ID: 5064086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.